Prognostic risk score for the survival of elderly patients with acute myeloid leukaemia comprising comorbidities
- 29 December 2012
- journal article
- Published by Springer Science and Business Media LLC in Medical Oncology
- Vol. 30 (1), 1-5
- https://doi.org/10.1007/s12032-012-0394-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Treating the Elderly Patient with Acute Myelogenous LeukemiaHematology, 2010
- Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trialsBritish Journal of Haematology, 2009
- Comorbidities and FLT3‐ITD abnormalities as independent prognostic indicators of survival in Elderly acute myeloid leukaemia patientsHematological Oncology, 2009
- Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemiaHaematologica, 2008
- Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemiaCancer, 2007
- The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.British Journal of Haematology, 2007
- Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2005
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemiaBritish Journal of Haematology, 2005
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976